k-Strophanthin-beta; k-Strophanthin-beta; Card-20(22)-enolide, 3-((2,6-dideoxy-4-O-beta-D-glucopyranosyl-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)-
⚠ EU RestrictedIdentification
CAS Number 560-53-2
EINECS / EC 209-210-9
CosIng Ref 82096
Chemical Name (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-3-[(2R,4S,5R,6R)-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
IUPAC Name —
Formula C36H54O14
Mol. Weight 710.8 g/mol
InChIKey FHIREUBIEIPPMC-SADZTDHOSA-N
Function & Classification
EU Regulatory Status
Safety Profile
No toxicology data available yet for this ingredient.
Check SCCS opinions or CIR reports for published safety assessments.
NOAEL · Dermal Absorption % · Sensitization
Formulation Guidelines
Usage level, pH range, solubility and addition phase not yet available.
Usage Level % · Addition Phase · Solubility
Suppliers & Documents
Log in to see suppliers.
Log in or register to see suppliers and documents for k-Strophanthin-beta; k-Strophanthin-beta; Card-20(22)-enolide, 3-((2,6-dideoxy-4-O-beta-D-glucopyranosyl-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)-.
Documents